(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)
GAO Mandates Revision Act of 2016
(Sec. 2) This bill eliminates provisions that require the Government Accountability Office (GAO) to:
(Sec. 3) The GAO must report annually (currently, every 60 days) on its oversight of the Troubled Asset Relief Program under the Emergency Economic Stabilization Act of 2008.
The Consumer Financial Protection Act of 2010 is amended to require the GAO to study financial services regulations periodically, as appropriate (currently, annually). The GAO is no longer required to analyze: (1) whether federal agencies are applying sound cost-benefit analysis in promulgating rules; or (2) efforts to avoid duplicative or conflicting rulemakings, information requests, or examinations.
The Dodd-Frank Wall Street Reform and Consumer Protection Act is amended to terminate the GAO's annual reporting after 2020, but require GAO reports in 2022 and 2024, about the effectiveness of disclosures relating to conflict minerals originating in the Democratic Republic of the Congo or adjoining countries on the rate of sexual- and gender-based violence and the promotion of peace and security in such areas.
The American Taxpayer Relief Act of 2012 is amended to extend until December 31, 2023, the GAO's deadline for updating a report under the Patient Protection and Affordable Care Act with an analysis of how the Department of Health and Human Services (HHS) has addressed GAO recommendations for the implementation of payment for oral-only ESRD (end-stage renal disease)-related drugs in the bundled prospective payment system under SSAct title XVIII provisions regarding Medicare coverage for ESRD patients.
The Public Health Service Act is amended to transfer from the GAO to HHS the responsibility to provide information, personnel, and administrative assistance to the review panel that consults with HHS about applications for demonstration grants that HHS awards to states for the development of alternatives to tort litigation for resolving disputes over injuries allegedly caused by health care providers or organizations.